Microscopic fibers in tissue are critical for our understanding of disease, but they have been difficult to study. Researchers at Stanford Medicine have come up with an easy way to visualize them.
In light of recent hypertension guideline updates, a Stanford Medicine cardiologist weighs in on lifestyle best practices, new interventions and how best to monitor your blood pressure at home.
Stanford Medicine researchers found that a smartphone could monitor patients with two types of muscular dystrophy as well as traditional methods and diagnose conditions more accurately — at no cost.
A dozen world-class vaccine experts convened to offer explanations and inspiration to scientists intent on improving our ability to ward off life-threatening infections.
Faculty and leaders shine light on methods for improving processes to ensure that rigor and reproducibility are core to scientific research — at Stanford University, nationwide and abroad.
Premature babies who heard recordings of their mothers reading to them had more mature white matter in a key language area of the brain, a Stanford Medicine-led study found.
Studying mice of different ages, Stanford Medicine scientists and colleagues found that neurons involved in spatial memory become less reliable later in life.
The cellular pathways linking wildfire smoke exposure to disease are just starting to be uncovered. A Stanford Medicine researcher explains what the knowledge will mean for heading off disease.
Stanford Medicine researchers found cells that keep a speech-linked protein called FOXP2 from clumping; its tricks could break apart clumps of proteins that cause devastating brain diseases.
“The phrase ‘Sugar feeds cancer’ is a dangerous statement,” says Stanford Medicine oncology dietitian Erika Connor. “It switches people’s anxiety on and sets them up for misinformation and panic.”
Many people are turning to marijuana for medical purposes and it may help for some. But older adults, in particular, should be aware of the risks to their health, Stanford Medicine experts caution.
The genetic variant APOE4, carried by one-fifth of the world’s people, substantially boosts Alzheimer’s risk. But scientists have been puzzled about how to reverse that risk: punch up the gene variant’s potency, or smack it down? Now we know.
Stanford Medicine researchers found cells that keep a speech-linked protein called FOXP2 from clumping; its tricks could break apart clumps of proteins that cause devastating brain diseases.
The series, "Wow! You do WHAT?!," offers a behind-the-scenes look at the diverse jobs and the exceptional individuals behind them that make Stanford Medicine one of a kind.
Targeted hope: The next era of acute myeloid leukemia care begins
Gabriel Mannis, MD, combines compassionate care with groundbreaking science — bringing clinical trial opportunities, like menin inhibitors, directly to patients.
Stanford neuroscientist Sergiu Pasca is pioneering technology to recreate human brain tissue and neural circuits in the lab – giving scientists unprecedented access to human brain development and opening new possibilities for treating disorders from...
Scientists in the lab of chemical engineer Monther Abu-Remaileh are uncovering the cellular functions that go awry in degenerative brain disorders and identifying therapies that could treat them.
‘Every failed experiment is a chance to learn faster’
Stanford biochemist Lingyin Li’s lab is studying a tumor-fighting “miracle molecule” that could one day inform therapies for cancer, as well as autoimmune, neurodegenerative, and age-related diseases.
‘The first experiments produced just jaw-dropping results’
Stanford neuro-oncologist Michelle Monje is pursuing a cure for a deadly pediatric brain cancer – and reshaping our understanding of how cancer and brain development intersect.
Stanford Medicine professors received several grants — to develop a treatment for a devastating genetic disease, enable advances in functional protein design, improve indoor air quality and create minimally invasive diagnostic tools. Two postdoctoral scholars were honored, one with a grant to support research into lung-brain communication; the other, with an award for his research into brain aging and cognitive decline.
Stanford Medicine is harnessing artificial intelligence to expedite research, advance treatments, improve patient care and achieve better health equity. Follow the latest developments in the integration of AI technologies into biomedicine.
Researchers and physicians at Stanford Medicine are expanding our understanding of how cancer originates and spreads, discovering more effective treatments, and helping prevent recurrence.
The latest news from Stanford Medicine's research and clinical communities as they uncover the secrets of conditions such as epilepsy, autism, stroke, Parkinson’s and Alzheimer’s disease and pioneer treatments for these conditions.
Researchers and physicians at Stanford Medicine are learning the origins of mental illness and finding more effective ways to treat conditions such as depression, anxiety, PTSD and bipolar disorder.
Stanford Medicine researchers are uncovering the secrets of heart conditions such as tachycardia, atrial fibrillation and heart failure while surgeons are advancing techniques for bypass operations, transplantation and fixing congenital heart deformities.
Gardner was known for her cystic fibrosis research, scientific integrity and work as a clinical pharmacologist guiding the development of new medicines.
Office of Communications is ready to assist with press materials and interview opportunities. Let us know how we can help you.\r\n"}}" style="background-color:;">
Media Inquiries
Have a media request? Our Office of Communications is ready to assist with press materials and interview opportunities. Let us know how we can help you.
If you are a reporter and would like to be added to our distribution list to receive press releases about Stanford Medicine's research, clinical breakthroughs and organizational updates, please fill out our request form.
